In this regard, our data show that HCC subtype follows this pattern, as low WWOX/HIF1A ratios activate PI3K/AKT, TNF-α, and Wnt pathways, driving proliferation and therapy resistance [113]. The gene discussed is TNF; the disease is hepatocellular carcinoma.